Product Program year 2025 Source: CMS Open Payments

Avitene Ultrafoam

Device Surgery

PDI 00801741010552

Open in the dashboard

General payments

$187,966

206 payments

Research payments

$0

0 payments

Through program year 2025, $187,966 in general payments and $0 in research payments were reported against Avitene Ultrafoam (Surgery).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $14,068 106
2024 General $170,236 30
2023 General $3,662 70

Breakdown

Who paid General payments · program years 2023–2025
  1. C. R. Bard, Inc. & Subsidiaries $169,889 12 payments
  2. Becton, Dickinson and Company $10,341 47 payments
  3. Davol Inc. $7,737 147 payments
Top recipients General payments · program year 2025
  1. Angela Bohnen Neurological Surgery · Littleton, CO $778 6% · 4 payments
  2. Heath Antoine Surgery · Somerset, NJ $650 5% · 1 payment
  3. Aaron Chevinsky Surgical Oncology · Milwaukee, WI $650 5% · 1 payment
  4. Linda Stanley Obstetrics & Gynecology · Galloway, NJ $650 5% · 1 payment
  5. Mark Frisch Obstetrics & Gynecology · Phila, PA $650 5% · 1 payment

The top 5 of 99 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Surgery $5,667 40% · 18 practitioners
  2. Obstetrics & Gynecology $2,029 14% · 5 practitioners
  3. Neurological Surgery $1,388 10% · 15 practitioners
  4. Urogynecology and Reconstructive Pelvic Surgery Obstetrics & Gynecology $1,300 9% · 2 practitioners
  5. General Practice $650 5% · 1 practitioner

The top 5 of 27 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Pennsylvania $5,372 38% · 14 recipients
  2. New Jersey $2,560 18% · 15 recipients
  3. Delaware $1,353 10% · 4 recipients
  4. Colorado $778 6% · 1 recipient
  5. Virginia $724 5% · 3 recipients

The top 5 of 24 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

206 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record